#news #biotech Testing for 63 gene variants identifies elevated risk for prostate cancer

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Testing for 63 gene variants identifies elevated risk for prostate cancer .A transatlantic team of scientists led by the London-based Institute of Cancer Research has developed a test that can identify men who are six times more likely to develop prostate cancer because of inherited risk. They believe their findings could improve screening, treatment and prevention of the disease.

from FierceBiotech: Biotech https://ift.tt/2Mfgbqy